Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2014 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DEXCOM INC | 16 | Q3 2023 | 6.3% |
ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
NATERA INC | 16 | Q3 2023 | 3.4% |
AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
MANNKIND CORP | 15 | Q3 2023 | 1.6% |
IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.